2.63
Schlusskurs vom Vortag:
$2.18
Offen:
$2.81
24-Stunden-Volumen:
31.82M
Relative Volume:
0.84
Marktkapitalisierung:
$6.68M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-4.11M
KGV:
-1.2127
EPS:
-2.1688
Netto-Cashflow:
$-3.23M
1W Leistung:
+234.69%
1M Leistung:
+105.47%
6M Leistung:
-7.07%
1J Leistung:
-15.16%
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Firmenname
Alaunos Therapeutics Inc
Sektor
Branche
Telefon
(346) 355-4099
Adresse
501 E LAS OLAS BLVD, FORT LAUDERDALE
Compare TCRT vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TCRT
Alaunos Therapeutics Inc
|
2.63 | 6.68M | 3,000 | -4.11M | -3.23M | -2.1688 |
|
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Fortgesetzt | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Aktie (TCRT) Neueste Nachrichten
Alaunos Therapeutics (TCRT) director Jaime Vieser receives 22,669 shares in lieu of board fees. - Stock Titan
Board fees are paid in 20,990 shares to Alaunos Therapeutics (TCRT) director Michael Allen Jerman. - Stock Titan
Alaunos Therapeutics Inc (NASDAQ: TCRT) Share Price, TCRT Stock News, TCRT Share Price & Updates - kalkine.ca
Alaunos Therapeutics Announces New Registered Direct Offering - The Globe and Mail
Alaunos Therapeutics Announces New Registered Direct Offering - TipRanks
Alaunos Therapeutics prices registered direct offering to raise ~$1.12 million - TradingView
Alaunos Therapeutics raises $1.12M in registered direct offering - Investing.com
Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules - manilatimes.net
TCRT Stock Pops On Volatile Spike As Traders Circle - StocksToTrade
TCRT Stock Spikes On Heavy Volume As Traders Hunt Volatility - timothysykes.com
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
TCRT Stock Sees Volatile Spike As Traders Target Momentum - timothysykes.com
Alaunos Therapeutics (TCRT) Holds Firm at $1.56 as Buyers Defend the Lower RangeMoving Average Crossovers - siam.in
Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportMcClellan Oscillator - siam.in
Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportPrice Target - careplusvn.com
Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportSentiment Shift - dars.gov.et
Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the DayCall Resistance - vinanet.vn
Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the DayIV Crush Alert - dars.gov.et
Alaunos (TCRT) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Market Move: The Stock Closes Near Unchanged in the Latest SessionAnnual Report - vinanet.vn
Alaunos (TCRT) EPS and Revenue: EPS Does Not Reach the Reported Estimate; Price Reaction: The Session Ends Near the Prior LevelAnalyst Coverage Count - vinanet.vn
Ziopharm: Q2 Earnings Snapshot - KTVB
Alaunos Therapeutics, Inc. Q2 2026: Revenue $0K, Net loss $988K, EPS $(0.41) — 10-Q Summary - TradingView
Alaunos Therapeutics (TCRT) warns on cash runway, Nasdaq compliance and losses - Stock Titan
Alaunos Therapeutics (TCRT) CEO granted 4,363 shares in lieu of cash salary - Stock Titan
Alaunos Therapeutics (TCRT) Holds Flat at $1.99 as Key Support and Resistance Levels Come into FocusTWAP Entry - dars.gov.et
Enterprise value to EBITDA forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
Alaunos Therapeutics Inc (TCRT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Alaunos Therapeutics (TCRT) Shows Modest Decline Amid Tight Range TradingVolume Breakout Ideas - careplusvn.com
Alaunos Therapeutics (TCRT) Shows Modest Decline Amid Tight Range TradingBearish Pattern Stocks - vinanet.vn
CEO Holger Weis takes Alaunos Therapeutics, Inc. (TCRT) stock instead of salary - Stock Titan
Alaunos Therapeutics, Inc. (TCRT) director receives 8,138-share board fee grant - Stock Titan
Alaunos Therapeutics (TCRT) director gets 8,789-share equity grant in lieu of fees - Stock Titan
Alaunos Therapeutics (TCRT) director granted 8,463 shares for board fees - Stock Titan
Alaunos Therapeutics Inc (TCRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alaunos Therapeutics Inc (TCRT) Cash Flow - TradingKey
Alaunos Therapeutics Inc (TCRT) Balance Sheet - TradingKey
Alaunos Therapeutics Inc (TCRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Alaunos Therapeutics Inc (TCRT) Institutional Confidence - TradingKey
Alaunos Therapeutics, Inc. Revenue Breakdown – NASDAQ:TCRT - TradingView
Alaunos Therapeutics Inc (TCRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TCRT|Alaunos Therapeutics Inc|Price:1.940|Chg%:+0.020 - TradingKey
Alaunos Therapeutics Inc (TCRT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alaunos Therapeutics (TCRT) Edges Higher as Stock Holds Above Key SupportMACD Signal Stocks - dars.gov.et
Alaunos Therapeutics (TCRT) Slips Over 1% as Biotech Sentiment Wavers — Key Levels to MonitorFibonacci Fan - careplusvn.com
Alaunos Therapeutics (TCRT) Edges Higher as Stock Holds Above Key SupportJelly Roll Trade - vinanet.vn
Price to earnings forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
TCRT Q4 2023 Earnings: EPS Misses Estimates Amid Ongoing Clinical FocusRevenue Report - vinanet.vn
Price to book forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
Enterprise value to revenue forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
Price to sales forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView
Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):